Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Launched by CASA DI CURA SAN RAFFAELE CASSINO · Sep 11, 2024

Keywords

ClinConnect Summary

The MARKERS-NDD trial is a study designed to learn more about neurodegenerative diseases, such as Parkinson's Disease, Alzheimer's Disease, and other related conditions. Researchers are collecting information from patients over time during their routine medical check-ups. They will look at various assessments, including brain scans, movement tests, and blood tests, to help identify new signs that could help doctors diagnose these diseases earlier and understand how they progress.

To participate in this trial, individuals must have a diagnosis of a neurodegenerative disease, such as Parkinson's Disease or dementia, and be willing to take part in the study. Importantly, there are no age limits, and anyone who can complete the study assessments is welcome. Participants can expect to undergo regular evaluations and tests, which will help researchers gather valuable information to improve future care and treatment for those affected by these conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with diagnosis of Parkinson's Disease, Parkinsonism and Movement Disorders
• • Patients with diagnosis of Parkinson's Disease
• • Diagnosis of Parkinson's Disease according to the United Kingdom (UK) Parkinson's Disease Society Brain Bank
• • Diagnosis of Movement Disorder not related to Parkinson's Disease
• • Diagnosis of Multiple System Atrophy (MSA) in accordance with Second Consensus Statement on Diagnosis of Multiple System Atrophy;
• • Diagnosis of Progressive Supranuclear Palsy according to Movement Disorder Society for Diagnosis of Progressive Supranuclear Palsy;
• • Diagnosis of Essential Tremor
• • Willing to participate in the study, understand the procedures and sign the informed consent.
• • Patients affected by cognitive impairment (CI) and dementia
• * Diagnosis of probable:
• • Lewy Body Dementia
• • Alzheimer's Disease
• • Mild Cognitive Decline
• • Subjective memory complaints
• • Willing to participate in the study, understand the procedures and sign the informed consent.
• Exclusion Criteria:
• • There are no restrictions for participation in the study based on age, severity of illness or presence of cognitive impairment, as long as the person is able to complete the research assessments.